Menu
Recruiting NCT07256951

Gen 2 Battrode Wear Study

No phase Interventional Adhesive Wear Time

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Adhesive.
Who it may be relevant to
Registry conditions: Adhesive Wear Time. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Validating adhesive wear time

Interventions

  • Device Adhesive
    14 day wear

Primary outcome measures

  • Wear time [Time frame: 15 days]

Eligibility criteria

Inclusion criteria

  • Participant is ≥ 18 years.
  • Completes the consent process as required.
  • Participants can speak and read English fluently.
  • Willing to allow shaving of device application area, as required.
  • Willing to take photos of the application area before wear, daily during wear, and immediately after removal.
  • Willingness to report current known pregnancy.

Exclusion criteria

  • Unable to comply with the study protocol and instructions for wearing the devices for up to 15 days.
  • Any pre-existing breached or compromised skin, skin rash, irritation or infection at the application area.
  • Any incision, wound or scar in the application area.
  • Participants with known skin allergies and sensitivities to adhesives.
  • Participants with scheduled electronic imaging (including magnetic resonance imaging), cardioversion, and/or procedures where device would be removed during the data collection period.
  • Participants with known history of cardiac arrhythmias.
  • Participants with chest anatomies not compatible with secure parasternal placement.
  • Use of clothing or garment that can dislodge or loosen the patch or bras with underwires or other worn items that might interfere with the devices under study.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Device feasibility

Study locations

United States · 1 center
  • Orange County Research Center — Lake Forest

Identifiers

NCT: NCT07256951 · BXU610410

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗